MAIA Biotechnology, Inc.
MAIA
$1.33
$0.021.53%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 30.28% | 53.72% | 19.66% | 97.44% | 16.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.00% | 28.10% | -13.73% | 123.49% | 35.40% |
| Operating Income | -61.00% | -28.10% | 13.73% | -123.49% | -35.40% |
| Income Before Tax | -48.56% | -41.01% | -1.59% | -225.41% | 39.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.56% | -41.01% | -1.59% | -225.41% | 39.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.56% | -41.01% | -1.59% | -225.41% | 39.78% |
| EBIT | -61.00% | -28.10% | 13.73% | -123.49% | -35.40% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 25.95% | 13.61% | 31.56% | -134.24% | 55.86% |
| Normalized Basic EPS | 25.93% | 13.54% | 31.61% | -134.08% | 55.86% |
| EPS Diluted | 25.95% | 13.61% | 31.56% | -134.24% | 55.86% |
| Normalized Diluted EPS | 25.93% | 13.54% | 31.61% | -134.08% | 55.86% |
| Average Basic Shares Outstanding | 100.64% | 63.24% | 48.53% | 38.95% | 36.47% |
| Average Diluted Shares Outstanding | 100.64% | 63.24% | 48.53% | 38.95% | 36.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |